Key result
Restenosis remains a major clinical challenge after coronary angioplasty, with most pharmacological interventions proving ineffective, though fish oils and mechanical strategies show some promise.
Why the study?
Do pharmacological or mechanical interventions prevent restenosis after coronary angioplasty?
Population
Patients undergoing coronary angioplasty for coronary atherosclerotic disease
Design
Review
Authors
Loading...
Most pharmacological approaches should not alter post-angioplasty restenosis management; leaves open roles for fish oils and mechanical strategies pending randomized trials.
Do pharmacological or mechanical interventions prevent restenosis after coronary angioplasty?
This review highlights that while restenosis remains a major challenge after coronary angioplasty with most pharmacological therapies proving ineffective, mechanical strategies like stents and potentially fish oils offer some promise.
VERNONANDERSON et al. (1993) conducted a review in Restenosis after coronary angioplasty. Pharmacological and mechanical interventions was evaluated. Restenosis remains a major clinical challenge after coronary angioplasty, with most pharmacological interventions proving ineffective, though fish oils and mechanical strategies show some promise.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: